Can RFK Jr. Limit Ozempic Access as HHS Chief? Here’s What to Know

President-elect Donald J. Trump is set to nominate Robert F. Kennedy Jr. to lead the Health and Human Services Department, where he would have limited power over drugs.

F.D.A.: Some Clonazepam Recalled Over Incorrect Doses on Labels

The drug, known by the brand name Klonopin, is used for panic disorder and seizures.

The New York Times Presents: ‘Weight of the World’ on Ozempic’s Rise

As GLP-1 medications like Ozempic soar in popularity, our new documentary follows three people on their weight-loss journeys — and explores how decades of diet culture paved the way for the drugs’ rise.

Orders for Morning-After Pills and Abortion Pills Rise After Trump’s Election

Some women are stocking up on the medications, saying they are concerned that the new administration could take steps to restrict access.

Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma

Donald Trump’s choice to run the Department of Health and Human Services spooked investors who worry what Kennedy would do.

Kennedy’s Views Mix Mistrust of Business With Unfounded Health Claims

President-elect Donald J. Trump’s pick for health secretary opposes fluoride in water, promotes unproven Covid therapies and has threatened to prosecute medical journals.

Don’t Blame Biden for Trump’s Victory

Readers respond to a guest essay by Josh Barro. Also: Elon Musk and America’s birthrate; a pharmacist’s view; the danger of extreme heat.

Court Hears New York Times Case Against European Commission Over Vaccine Deal

The news outlet is pushing the Commission to release text messages between the E.U.’s top official and Pfizer as they negotiated a Covid-19 vaccine contract.

Can America’s Health Survive Robert F. Kennedy Jr.?

What Kennedy gets right.